Prof.Dr.Dr.hc mult Peter Ferenci
Department of Medicine III (Division of Gastroenterology and Hepatology)
Position: Associate Professor
ORCID: 0000-0003-2306-1992
T +43 1 40400 49450
peter.ferenci@meduniwien.ac.at
Keywords
Genetic Diseases, Inborn; Liver Diseases
Research interests
Besides many areas of clinical hepatology I am focussed on the genotype-phenotype association in Wilson disease. Furthermore I am studying possible cofactors for disease expression.
Techniques, methods & infrastructure
Genetic testing
Selected publications
- Stättermayer, A.F. et al. (2015) ‘Hepatic steatosis in Wilson disease – Role of copper and PNPLA3 mutations’, Journal of Hepatology, 63(1), pp. 156–163. Available at: http://dx.doi.org/10.1016/j.jhep.2015.01.034.
- Stättermayer, A.F. et al. (2017) ‘Low hepatic copper content and PNPLA3 polymorphism in non-alcoholic fatty liver disease in patients without metabolic syndrome’, Journal of Trace Elements in Medicine and Biology, 39, pp. 100–107. Available at: http://dx.doi.org/10.1016/j.jtemb.2016.08.006.
- Ferenci, P. et al. (2014) ‘ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV’, New England Journal of Medicine, 370(21), pp. 1983–1992. Available at: http://dx.doi.org/10.1056/nejmoa1402338.
- Ferenci, P. (2014) ‘Phenotype-genotype correlations in patients with Wilson’s disease’, Annals of the New York Academy of Sciences, 1315(1), pp. 1–5. Available at: http://dx.doi.org/10.1111/nyas.12340.
- Ferenci P, Członkowska A, Merle U, Szalay F, Gromadzka G, Yurdaydin C, Vogel W, Bruha R, Schmidt HT, Stremmel W. Late onset Wilson disease. Gastroenterology 2007;132:1294-1298